Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni

Frontiers in Cardiovascular Medicine

article

Nobuko Kojima¹  Hayato Tada¹  Hirofumi Okada¹  Shohei Yoshida¹  Kenji Sakata¹  Soichiro Usui¹  Hiroko Ikeda²  Masaki Okajima³  Masa-aki Kawashiri¹  Masayuki Takamura¹ 

[1] Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences;Diagnostic Pathology, Kanazawa University Hospital;Department of Emergency Medicine, Kanazawa University Hospital

关键词: cardiomyopathy;    left ventricle;    chest pain;    myocarditis;    COVID-19;   

DOI  :  10.3389/fcvm.2022.837759

学科分类：地球科学(综合)

来源: Frontiers

【 摘 要 】

We herein present our experience with a case involving a 17-year-old Japanese boy suffering from acute myocarditis after his second coronavirus disease-2019 (COVID-19) messenger RNA (mRNA) vaccine shot. The patients had a history of myocarditis associated with Campylobacter jejuni 3 years prior. This has been the first-ever documented case of myocarditis associated with COVID-19 mRNA vaccination in a patient with a history of myocarditis. We present a series of images and blood biomarkers for different types of myocarditis that developed in this single patient.

【 授权许可】

CC BY